IQE plc
("IQE" or the "Company")
02 October 2008
Application has been made to the London Stock Exchange for 54,496
ordinary shares of 1p each in the Company ('Ordinary Shares') to be
admitted to trading on AIM. The Ordinary Shares are being issued
pursuant to the exercise of share options by an employee under the
IQE Group Share Option Scheme. The Ordinary Shares have been issued
at the following prices:
Price of issue Number of Ordinary Shares
Total at 5.63p
11,649
Total at 6.67p
28,825
Total at 6.87p
3,260
Total at 7.10p
10,762
TOTAL
54,496
Admission to trading on AIM of these Ordinary Shares is expected to
occur on 8 October 2008.
Following this issue the total number of Ordinary Shares in issue
will be 433,084,688.
Contacts:
IQE plc (+44 29 2083 9400)
Chris Meadows
Phil Rasmussen
Leslie Coventry
Noble & Company Limited (+ 44 20 7763 2200)
John Llewellyn-Lloyd
Sam Reynolds
Panmure Gordon (UK) Limited (+44 20 7459 3600)
Aubrey Powell
Ashton Clanfield
---END OF MESSAGE---
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.